Stefan Endres

36.6k total citations · 15 hit papers
276 papers, 28.6k citations indexed

About

Stefan Endres is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Stefan Endres has authored 276 papers receiving a total of 28.6k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Immunology, 67 papers in Oncology and 62 papers in Molecular Biology. Recurrent topics in Stefan Endres's work include Immune Response and Inflammation (86 papers), Immunotherapy and Immune Responses (83 papers) and Immune Cell Function and Interaction (63 papers). Stefan Endres is often cited by papers focused on Immune Response and Inflammation (86 papers), Immunotherapy and Immune Responses (83 papers) and Immune Cell Function and Interaction (63 papers). Stefan Endres collaborates with scholars based in Germany, United States and Switzerland. Stefan Endres's co-authors include Gunther Hartmann, Veit Hornung, Simon Rothenfußer, Andreas Eigler, Sebastian Kobold, Thomas Giese, Anne Krug, Hendrik Poeck, Charles A. Dinarello and Max Schnurr and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Stefan Endres

270 papers receiving 27.8k citations

Hit Papers

5'-Triphosphate RNA Is the Ligand for RIG-I 1989 2026 2001 2013 2006 2002 1989 2005 1990 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 5'-Triphosphate RNA Is the Ligand for RIG-I
    2006 1.9k citations Veit Hornung, Hendrik Poeck et al. profile →
  2. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides
    2002 1.6k citations Veit Hornung, Simon Rothenfußer et al. profile →
  3. The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells
    1989 1.6k citations Stefan Endres et al. profile →
  4. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
    2005 967 citations Veit Hornung, Carole Bourquin et al. profile →
  5. Correlations and interactions in the production of interleukin-6 (IL- 6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
    1990 840 citations Stefan Endres et al. profile →
  6. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
    2010 755 citations Peter Duewell, M Dauer et al. profile →
  7. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence
    2009 742 citations Hendrik Poeck, Stefan Endres et al. profile →
  8. Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
    2001 735 citations Simon Rothenfußer, Veit Hornung et al. profile →
  9. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12
    2001 628 citations Simon Rothenfußer, Veit Hornung et al. profile →
  10. Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
    1990 623 citations Stefan Endres et al. profile →
  11. Oral (n-3) Fatty Acid Supplementation Suppresses Cytokine Production and Lymphocyte Proliferation: Comparison between Young and Older Women
    1991 551 citations Stefan Endres et al. profile →
  12. Interleukins in cancer: from biology to therapy
    2021 528 citations Daria Briukhovetska, Janina Dörr et al. profile →
  13. Advances in cancer immunotherapy 2019 – latest trends
    2019 400 citations Sebastian Kobold, Bruno L. Cadilha et al. profile →
  14. Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
    2019 377 citations Mohamed-Reda Benmebarek, Bruno L. Cadilha et al. profile →
  15. Teaching an old dog new tricks: next-generation CAR T cells
    2018 329 citations Stefan Endres, Michael von Bergwelt‐Baildon et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Endres Germany 83 16.6k 9.0k 5.0k 3.5k 2.4k 276 28.6k
Edward J. Pearce United States 81 17.7k 1.1× 9.5k 1.1× 4.1k 0.8× 4.2k 1.2× 1.8k 0.8× 227 36.1k
Niels Borregaard Denmark 88 13.4k 0.8× 10.2k 1.1× 2.1k 0.4× 2.8k 0.8× 1.5k 0.6× 254 30.0k
Richard S. Blumberg United States 94 16.4k 1.0× 11.0k 1.2× 3.9k 0.8× 5.0k 1.4× 1.8k 0.8× 321 34.0k
Klaus Pfeffer Germany 77 14.1k 0.8× 9.2k 1.0× 4.1k 0.8× 4.7k 1.4× 755 0.3× 266 28.3k
Lars Eckmann United States 78 9.8k 0.6× 8.2k 0.9× 3.7k 0.7× 3.5k 1.0× 1.3k 0.6× 238 25.5k
Samuel D. Wright United States 86 13.9k 0.8× 9.6k 1.1× 2.6k 0.5× 4.3k 1.2× 1.2k 0.5× 219 29.2k
Terje Espevik Norway 84 15.3k 0.9× 8.5k 0.9× 2.1k 0.4× 5.1k 1.5× 1.0k 0.4× 316 29.2k
Zhigang Tian China 82 15.2k 0.9× 7.0k 0.8× 6.1k 1.2× 4.9k 1.4× 795 0.3× 450 27.3k
Kenya Honda Japan 63 14.8k 0.9× 13.6k 1.5× 3.7k 0.7× 4.1k 1.2× 905 0.4× 129 29.9k
Luciano Adorini Italy 80 10.8k 0.6× 4.8k 0.5× 4.3k 0.9× 4.4k 1.3× 1.5k 0.6× 338 24.8k

Countries citing papers authored by Stefan Endres

Since Specialization
Citations

This map shows the geographic impact of Stefan Endres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Endres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Endres more than expected).

Fields of papers citing papers by Stefan Endres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Endres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Endres. The network helps show where Stefan Endres may publish in the future.

Co-authorship network of co-authors of Stefan Endres

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Endres. A scholar is included among the top collaborators of Stefan Endres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Endres. Stefan Endres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Sophia, Adrian Gottschlich, Janina Dörr, et al.. (2024). Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunology Immunotherapy. 73(6). 100–100. 2 indexed citations
2.
Thompson, Jeffrey, Tobias Dreischulte, Olga Barreiro, et al.. (2023). Association between bisphosphonate use and COVID-19 related outcomes. eLife. 12. 4 indexed citations
3.
Cadilha, Bruno L., Mohamed-Reda Benmebarek, Florian Märkl, et al.. (2023). Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy. British Journal of Cancer. 129(4). 696–705. 10 indexed citations
4.
Huynh, Duc, Pia Winter, Florian Märkl, Stefan Endres, & Sebastian Kobold. (2022). Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment. Seminars in Immunopathology. 45(2). 215–227. 12 indexed citations
5.
Stock, Sophia, Mohamed-Reda Benmebarek, Christian Jöst, et al.. (2022). Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors. Journal for ImmunoTherapy of Cancer. 10(7). e005054–e005054. 19 indexed citations
6.
Mann, Carina C. de Oliveira, Stephan A. Müller, Michael Kluge, et al.. (2021). OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis. Science Immunology. 6(61). 29 indexed citations
7.
Metzger, Philipp, Sabrina V. Kirchleitner, Steffen Ormanns, et al.. (2020). Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer Immunology Immunotherapy. 69(10). 2101–2112. 14 indexed citations
8.
Helms, Mike W., Kerstin Jahn‐Hofmann, Felix Gnerlich, et al.. (2019). Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy. Molecular Cancer Therapeutics. 18(12). 2343–2356. 13 indexed citations
9.
Eckardt, Bernd, et al.. (2018). Advanced Vehicle Charging Solutions Using SiC and GaN Power Devices. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 1–6. 8 indexed citations
10.
Piseddu, Ignazio, Gabriela M. Wiedemann, Michael Lauseker, et al.. (2018). CCL1 is a major regulatory T cell attracting factor in human breast cancer. BMC Cancer. 18(1). 1278–1278. 58 indexed citations
11.
Anz, David, Moritz Rapp, Stephan Eiber, et al.. (2015). Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression. Cancer Research. 75(21). 4483–4493. 63 indexed citations
12.
Wei, Jiwu, Peter Duewell, Sabine Hoves, et al.. (2013). Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer. Cancer Research. 73(6). 1709–1720. 123 indexed citations
13.
Bourquin, Carole, C. Hotz, Daniel Noerenberg, et al.. (2011). Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance. Cancer Research. 71(15). 5123–5133. 68 indexed citations
14.
Sandholzer, Nadja, et al.. (2011). CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice. Clinical Cancer Research. 17(7). 1765–1775. 199 indexed citations
15.
Schmidt, Andreas, Tobias Schwerd, Johannes C. Hellmuth, et al.. (2009). 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proceedings of the National Academy of Sciences. 106(29). 12067–12072. 325 indexed citations
16.
Besch, Robert, Hendrik Poeck, Tobias Hohenauer, et al.. (2009). Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cells. Journal of Clinical Investigation. 119(8). 2399–411. 350 indexed citations
17.
Obermaier, Bianca, et al.. (2003). Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biological Procedures Online. 5(1). 197–203. 70 indexed citations
18.
Sinha, Bhanu, et al.. (1998). Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells. Research in Immunology. 149(2). 139–150. 27 indexed citations
19.
Eigler, Andreas, Bhanu Sinha, & Stefan Endres. (1993). Nitric Oxide-Releasing Agents Enhance Cytokine-Induced Tumor Necrosis Factor Synthesis in Human Mononuclear Cells. Biochemical and Biophysical Research Communications. 196(1). 494–501. 57 indexed citations
20.
Christensen, Jens Hesselbjerg, Peter Gustenhoff, Ejler Ejlersen, et al.. (1993). The effect of n-3 polyunsaturated fatty acids on cardiac ventricular arrhythmias - a pilot study.. 5(4). 151–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward J. Pearce Breakdown of academic impact, for papers by Niels Borregaard Breakdown of academic impact, for papers by Richard S. Blumberg Breakdown of academic impact, for papers by Klaus Pfeffer Breakdown of academic impact, for papers by Lars Eckmann Breakdown of academic impact, for papers by Samuel D. Wright Breakdown of academic impact, for papers by Terje Espevik Breakdown of academic impact, for papers by Zhigang Tian Breakdown of academic impact, for papers by Kenya Honda Breakdown of academic impact, for papers by Luciano Adorini
Rankless by CCL
2026